Trial intelligence / Profile preview

LOWOL: Plenvu vs Citrafleet for Screening Colonoscopy

NCT04297423Phase 4Completed

Sponsor
Hospital Clínic de Barcelona
Start
Mar 2020
Primary completion
Jun 2022
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

A Phase 4 trial of polyethylene glycol + electrolytes + ascorbic acid in colorectal cancer (CRC), sponsored by Hospital Clínic de Barcelona. Started Mar 2020; status: completed.

02

Drugs

polyethylene glycol + electrolytes + ascorbic acid
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT04297423.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04297423.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call